Nascent Biotech (OTCMKTS:NBIO) Stock Crosses Below 50-Day Moving Average – Time to Sell?

Nascent Biotech, Inc. (OTCMKTS:NBIO – Get Free Report) passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.01 and traded as low as $0.0002. Nascent Biotech shares last traded at $0.0043, with a volume of 5,157 shares trading hands.

Nascent Biotech Trading Up 48.3%

The company has a 50 day moving average of $0.01.

About Nascent Biotech

(Get Free Report)

Nascent Biotech, Inc, a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer.

Featured Stories

• Five stocks we like better than Nascent Biotech
• Stock Dividend Cuts Happen Are You Ready?
• Keysight Technologies’ Surge: The Market Wakes Up to This AI Play
• TSX Venture Exchange (Formerly Canadian Venture Exchange)
• Is American Express the Credit Stock For a K-Shaped Economy?
• What is the S&P/TSX Index?
• Powering Up: How a Credit Upgrade Fuels Vistra’s AI Ambitions